Diagnsticos (Brazil) Insiders

DASA3 Stock  BRL 2.11  0.05  2.43%   
Diagnsticos employs about 24 people. The company is managed by 10 executives with a total tenure of roughly 54 years, averaging almost 5.0 years of service per executive, having 2.4 employees per reported executive. Breaking down Diagnsticos' management performance can provide insight into the firm performance.
Pedro Bueno  CEO
Chief Executive Officer, Director
Octavio Silva  President
Member of the Executive Board, Vice President of Operations
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Diagnsticos da Amrica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Diagnsticos Management Team Effectiveness

The company has return on total asset (ROA) of 0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.

Diagnsticos Workforce Comparison

Diagnsticos da Amrica is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 18,546. Diagnsticos adds roughly 24.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Diagnsticos da Amrica Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Diagnsticos da Amrica Price Series Summation is a cross summation of Diagnsticos price series and its benchmark/peer.

Diagnsticos Notable Stakeholders

A Diagnsticos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Diagnsticos often face trade-offs trying to please all of them. Diagnsticos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Diagnsticos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pedro BuenoChief Executive Officer, DirectorProfile
Octavio SilvaMember of the Executive Board, Vice President of OperationsProfile
Adriano LimaExecutive Vice President of Human ResourcesProfile
Ricardo OrlandoChief Information TechnologyProfile
Ricardo SIlvaPrivate and Hospitals Businesses OfficerProfile
Emerson GasparettoRadiology and Graphic Methods Officer, Member of the Executive BoardProfile
Carlos NetoChief DirectorProfile
Linaldo JuniorChief OfficerProfile
Fbio CunhaChief OfficerProfile
Felipe GuimaraesChief OfficerProfile

About Diagnsticos Management Performance

The success or failure of an entity such as Diagnsticos da Amrica often depends on how effective the management is. Diagnsticos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Diagnsticos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Diagnsticos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Diagnsticos da Amrica S.A. provides diagnostic test services in Latin America. Diagnsticos da Amrica S.A. is a subsidiary of Cromossomo Participaes II S.A. DASA ON operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange.
Please note, the imprecision that can be found in Diagnsticos' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Diagnsticos da Amrica. Check Diagnsticos' Beneish M Score to see the likelihood of Diagnsticos' management manipulating its earnings.

Diagnsticos Workforce Analysis

Traditionally, organizations such as Diagnsticos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Diagnsticos within its industry.

Diagnsticos Manpower Efficiency

Return on Diagnsticos Manpower

Revenue Per Employee434.1M
Revenue Per Executive1B
Net Loss Per Employee9.4M
Net Loss Per Executive22.7M

Additional Tools for Diagnsticos Stock Analysis

When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.